| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Apr―08 |
In-Silico Screening of Mitragynine Derivates from the Genus Mitragyna Korth Targeting the Main Protease of the SARS-COV-2 |
Islamudin Ahmad, Nur Masyithah Zamruddin, M. Arifuddin, Yuspian Nur, Firzan Nainu |
| 2 |
[GO] |
2026―Apr―08 |
Molecular Docking Study of Nigella sativa Alkaloid Compounds as the Inhibitor of Papain-Like Protease SARS-CoV-2 |
Gusnia Meilin Gholam, Iman Akhyar Firdausy |
| 3 |
[GO] |
2026―Apr―08 |
Analysis of SARS-CoV-2 Spike Protein as The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study |
Taufik Muhammad Fakih, Mentari Luthfika Dewi |
| 4 |
[GO] |
2026―Apr―08 |
Effectiveness of Antiviral Drugs as Covid-19 Therapy |
Adelia Firandi, Didik Hasmono |
| 5 |
[GO] |
2026―Apr―08 |
Ulquts Al Hindi (Sasereus sp) has Candidate Covid-19 drug Through Regulation of Cytokines Produced by the Innate Immune System |
Noviyanty Indjar Gama, Hajrah Hajrah, Helmi Helmi, Ysrafil Ysrafil |
| 6 |
[GO] |
2023―Dec―31 |
In-Silico Screening of Mitragynine Derivates from the Genus Mitragyna Korth Targeting the Main Protease of the SARS-COV-2 |
Islamudin Ahmad, Nur Masyithah Zamruddin, M. Arifuddin, Yuspian Nur, Firzan Nainu |
| 7 |
[GO] |
2023―Oct―04 |
Molecular Docking Study of Nigella sativa Alkaloid Compounds as the Inhibitor of Papain-Like Protease SARS-CoV-2 |
Gusnia Meilin Gholam, Iman Akhyar Firdausy |
| 8 |
[GO] |
2021―Dec―24 |
Analysis of SARS-CoV-2 Spike Protein as The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study |
Taufik Muhammad Fakih, Mentari Luthfika Dewi |
| 9 |
[GO] |
2021―Jul―05 |
Effectiveness of Antiviral Drugs as Covid-19 Therapy |
Adelia Firandi, Didik Hasmono |
